Director/PDMR Shareholding
April 26 2010 - 2:00AM
UK Regulatory
TIDMLPX
RNS Number : 7399K
Lipoxen PLC
26 April 2010
+---------------------------------+---------------------------------+
| For immediate release | 26 April 2010 |
+---------------------------------+---------------------------------+
Lipoxen PLC
('Lipoxen' or 'the Company')
DIRECTOR DEALING
Lipoxen PLC (AIM: LPX), a bio-pharmaceutical company specialising in the
development of high-value differentiated biologicals, vaccines and siRNA
delivery, has been informed that certain directors have acquired ordinary shares
of 0.5 pence each (the "New Ordinary Shares"). Details of the director dealings
are set out in the table below:
+-------------+----------+---------+----------+-----------+----------+
| Name | Date | Price | Shares | Total | % of |
| | | | acquired | interest | total |
| | | | | | issued |
| | | | | | share |
| | | | | | capital |
+-------------+----------+---------+----------+-----------+----------+
| Scott | 23 April | 6.95p | 100,000 | 1,401,362 | 0.82 |
| Maguire | 2010 | | | | |
+-------------+----------+---------+----------+-----------+----------+
| Colin Hill | 23 April | 6.83p | 150,000 | 1,825,420 | 1.06 |
| | 2010 | | | | |
+-------------+----------+---------+----------+-----------+----------+
| | | | | | |
+-------------+----------+---------+----------+-----------+----------+
- Ends -
For further information please contact:
+------------------------------------------+--------------------+
| Lipoxen plc | +44 (0)20 7389 |
| | 5015 |
+------------------------------------------+--------------------+
| M. Scott Maguire, Chief Executive | |
| Officer | |
+------------------------------------------+--------------------+
| | |
+------------------------------------------+--------------------+
| Singer Capital Markets (nominated | +44 (0)20 3205 |
| adviser) | 7500 |
+------------------------------------------+--------------------+
| Jeff Keating / Claes Spång | |
+------------------------------------------+--------------------+
| | |
+------------------------------------------+--------------------+
| Buchanan Communications | +44 (0)20 7466 |
| | 5000 |
+------------------------------------------+--------------------+
| Lisa Baderoon / Catherine Breen | |
+------------------------------------------+--------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSFMGZDVFRGGZM
Lipoxen (LSE:LPX)
Historical Stock Chart
From May 2024 to Jun 2024
Lipoxen (LSE:LPX)
Historical Stock Chart
From Jun 2023 to Jun 2024